HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹267 Cr | ₹257 Cr | ₹341 Cr | ₹323 Cr | ₹273 Cr |
What is the latest Operating Profit of HIKAL ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹267 Cr |
| Mar2024 | ₹257 Cr |
| Mar2023 | ₹341 Cr |
| Mar2022 | ₹323 Cr |
| Mar2021 | ₹273 Cr |
How is Operating Profit of HIKAL Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹267 Cr | 3.86 | |
| Mar2024 | ₹257 Cr | -24.51 | |
| Mar2023 | ₹341 Cr | 5.47 | |
| Mar2022 | ₹323 Cr | 18.20 | |
| Mar2021 | ₹273 Cr | - | |
Compare Operating Profit of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹1,922.2 Cr | -7.6% | -22.3% | -59.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,837.0 Cr | 1% | 3.8% | 0.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,175.0 Cr | -1.7% | -4.1% | 3.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,394.0 Cr | -0% | -3% | 33.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,999.0 Cr | -1.3% | -1.3% | 8.6% | Stock Analytics | |
| CIPLA | ₹100,379.0 Cr | -1.1% | -6.3% | -18.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -7.6% |
-22.3% |
-59.7% |
| SENSEX | -0.8% |
-11.7% |
-3.6% |
You may also like the below Video Courses